Sunday September 3, 2023 |
15:30 | Registration |
|
17:10 | Opening Ceremony |
Dr Vesna GABELICA MARKOVIC (CROATIAN CHEMICAL SOCIETY, MEDICINAL & PHARMACEUTICAL CHEMISTRY SECTION, Zagreb, Croatia) Prof. Karl GADEMANN (UNIVERSITY OF ZÜRICH, Zürich, Switzerland) Dr Ingo HARTUNG (MERCK HEALTHCARE, Darmstadt, Germany) Prof. Rui MOREIRA (UNIVERSITY OF LISBON, Lisbon, Portugal) |
17:30 | Opening Lecture Synthetic and Medicinal Chemistry for Biologics (IL01) |
Prof. Jeffrey BODE (ETH ZURICH, Zürich, Switzerland) |
18:30 | Welcome Reception |
|
Monday September 4, 2023 |
08:00 | Registration |
|
| Session 1 |
|
| Session Chair |
Dr Luc VAN HIJFTE (SYMERES, Nijmegen, The Netherlands) |
08:30 | Innovation in Synthetic Fluorine Chemistry through Use of Flow (IL02) |
Prof. Timothy NOËL (UNIVERSITY OF AMSTERDAM, Amsterdam, The Netherlands) |
09:15 | MicroCycle: A Machine Learning Driven, Automated and Integrated Platform for Drug Discovery (IL03) |
Dr Cara BROCKLEHURST (NOVARTIS, Basel, Switzerland) |
10:00 | Divergent Synthesis as an Emergent Tool for Drug Discovery (OC01) |
Prof. Alexandros ZOGRAFOS (ARISTOTLE UNIVERSITY OF THESSALONIK, THESSALONIKI, Greece) |
10:15 | Coffee-break and Exhibition |
|
10:45 | Synthesis of Fluorinated Molecules Using Modern Synthetic Tools (IL04) |
Dr Tatiana BESSET (INSA OF ROUEN, Mont-Saint-Aignan, France) |
11:30 | Chemical Probes and their Relevance for Drug Discovery Programs – Examples from the Endocannabinoid System (IL05) |
Dr Uwe GRETHER (F. HOFFMANN-LA ROCHE, Basel, Switzerland) |
12:15 | Isolation and Biological Activities of Natural Products and Analogues from the Adriatic Coral Eunicella Cavolini (OC02) |
Prof. Dean MARKOVIC (UNIVERSITY OF RIJEKA, Rijeka, Croatia) |
12:30 | Lunch and Exhibition |
|
13:15 | Poster Session 1 |
|
| Session 2 |
|
| Session Chair |
Dr Sanja KOSTRUN (SELVITA LTD., Zagreb, Croatia) |
14:30 | New Catalytic Approaches for Simplifying Complex Amine Synthesis (IL06) |
Prof. Darren J. DIXON (UNIVERSITY OF OXFORD, Oxford, United Kingdom) |
15:15 | Challenges and Opportunities in CNS Drug Discovery (IL07) |
Dr Frauke POHLKI (ABBVIE, Ludwigshafen, Germany) |
16:00 | Design and Optimization of High Performance KSPi ADCs With Increased Tumor Selectivity: Enhancing the Therapeutic Window by Legumain-Mediated ADC Activation (OC03) |
Dr Anne-Sophie REBSTOCK (VINCERX, Monheim am Rhein, Germany) |
16:15 | Coffee-break and Exhibition |
|
16:45 | Enabling Technologies to Drive the MSD Portfolio (IL08) |
Dr Rebecca RUCK (MERCK, SHARP & DOHME, Rahway, United States) |
17:30 | Empowering Organic Synthesis: From Unique Methods to Complex Natural Products (IL09) |
Prof. David SARLAH (UNIVERSITY OF ILLINOIS, Urbana, United States) |
18:15 | Closing of the day |
|
Tuesday September 5, 2023 |
08:30 | Session 3 |
|
| Session Chair |
Prof. Maria Laura BOLOGNESI (UNIVERSITY OF BOLOGNA, Bologna, Italy) |
08:30 | Making Difficult-to-Make Molecules: Photochemistry as an Enabling Tool (IL25) |
Dr Susannah COOTE (UNIVERSITY OF BATH, Bath, United Kingdom) |
09:15 | Structure Based Identification of Novel Albumin Binders for Half-Life Extensions of Proteins and Peptides (IL11) |
Dr Maria MÉNDEZ PÉREZ (SANOFI-AVENTIS DEUTSCHLAND GMBH, Frankfurt, Germany) |
10:00 | High-Throughput Protac Synthesis and Direct to Biology Assaying for Rapidly Evaluating Targeted Protein Degradation (OC04) |
Dr Afjal MIAH (GLAXOSMITHKLINE, Stevenage, United Kingdom) |
10:15 | Coffee-break and Exhibition
|
|
10:45 | Phenotypic Screen to NLRP3 lead (IL12) |
Dr Daniel OEHLRICH (JANSSEN RESEARCH AND DEVELOPMENT, Beerse, Belgium) |
11:30 | Genochemetic Diversification of Natural Products (IL13) |
Prof. Rebecca GOSS (UNIVERSITY OF ST ANDREWS, St Andrews, United Kingdom) |
12:15 | Development of Selective mTOR Inhibitors for the Treatment of Cancer and Neurological Disorders (OC05) |
Dr Chiara BORSARI (UNIVERSITY OF MILAN, Milan, Italy) |
12:30 | Lunch and Exhibition
|
|
13:15 | Poster Session 2 |
|
14:30 | Session 4 |
|
| Session Chair |
Dr Ingo HARTUNG (MERCK HEALTHCARE, Darmstadt, Germany) |
14:30 | Next Generation Design-Make-Test-Analysis-Cycles (IL14) |
Dr Clara CHRIST (BAYER, Berlin, Germany) |
15:15 | Making and Breaking of C-S Bonds Using Metal Catalysis (IL15) |
Dr Ivana FLEISCHER (UNIVERSITY OF TÜBINGEN, Tuebingen, Germany) |
16:00 | Discovery of Imidazo[1,2-a]Pyridine Carboxamide BAY 1165747, a Long-Acting Soluble Guanylate Cyclase Stimulator for Resistant Hypertension (OC06) |
Dr Alexandros VAKALOPOULOS (BAYER, Wuppertal, Germany) |
16:15 | Coffee-break and Exhibition
|
|
16:45 | From BRD4 to KRAS: 12 Years of Oncology Small Molecules (IL16) |
Dr Darryl MCCONNELL (BOEHRINGER INGELHEIM, Austria) |
17:30 | Synthesis of Glycosylated Natural Products or Analogues of Biological Interest (IL17) |
Dr Stéphanie NORSIKIAN (INSTITUT DE CHIMIE DES SUBSTANCES NATURELLES, Gif-sur-Yvette, France) |
18:15 | Closing of the day
|
|
Wednesday September 6, 2023 |
08:30 | Session 5 |
|
| Session Chair |
Dr Werngard CZECHTIZKY (ASTRAZENECA, Mölndal, Sweden) |
08:30 | Machine Learning to Accelerate Design-Make-Test Cycles (IL18) |
Dr Marwin SEGLER (MICROSOFT RESEARCH, Cambridge, United Kingdom) |
09:15 | Covalent Chemical Biology with Natural Products and Novel Synthetic Warheads (IL19) |
Prof. Thomas POULSEN (AARHUS UNIVERSITY, Aarhus C, Denmark) |
10:00 | Direct Access to Unnatural Drug-Like Molecules by Photocatalytic Late-Stage Functionalization (OC07) |
Prof. Olga GARCIA MANCHENO (UNIVERSITY OF MÜNSTER, Münster, Germany) |
10:15 | Coffee-break and Exhibition
|
|
10:45 | Multicomponent Alkene Cross-Coupling by Base Metal Catalysis (IL20) |
Dr Ming Joo KOH (NATIONAL UNIVERSITY OF SINGAPORE, Singapore, Singapore) |
11:30 | Novel, Reversible DCAF1 Ligands Expand the TPD-Toolbox (IL21) |
Dr Martin SCHRÖDER (NOVARTIS, Basel, Switzerland) Dr Anna VULPETTI (NOVARTIS, Basel, Switzerland) |
12:15 | Cocktails For 19F NMR Fragment Screening: From Theory to Applications Using Enamine’s Stock Chemical Space (OC08) |
Prof. Dmytro VOLOCHNYUK (ENAMINE LTD, Kyiv, Ukraine) |
12:30 | Lunch and Exhibition
|
|
13:15 | Poster Session 3
|
|
14:30 | Session 6 |
|
| Session Chair |
Prof. Rui MOREIRA (UNIVERSITY OF LISBON, Lisbon, Portugal) |
14:30 | Disrupting the YAP-TEAD Protein-Protein Interaction with Small Molecules - Discovery of Drug Candidate NVP-IAG933 (IL22) |
Dr Nicolas SOLDERMANN (NOVARTIS, Basel, Switzerland) |
15:15 | EFMC Prizes Session - Ceremony & Lectures |
|
15:20 | EFMC Prize for a Young Medicinal Chemist or Chemical Biologist in Academia Targeted Protein Degradation via Molecular Glues (PR01) |
Dr Georg WINTER (RESEARCH CENTER FOR MOLECULAR MEDICINE OF THE AUSTRIAN ACADEMY OF SCIENCES, Vienna, Austria) |
15:35 | EFMC Prize for a Young Medicinal Chemist or Chemical Biologist in Industry
Discovery and Characterization of Potent, Efficacious and Orally Available Antimalarial Plasmepsin X Inhibitors (PR02) |
Dr Teresa DE HARO GARCIA (UCB, Braine l'Alleud, Belgium) |
15:50 | EFMC-YMCS 2022 Best Oral Communication (OC09)
Epitope Identification Using In-Silico Approaches, a Case Study: Nanobodies Binding to MGlu5 Receptor |
Ms Floriane ESHAK (UNIVERSITY PARIS CITÉ, Paris, France) |
16:05 | EFMC Best Practices Working Group |
Prof. Anders BACH (UNIVERSITY OF COPENHAGEN, Copenhagen, Denmark) |
16:15 | Coffee-break and Exhibition
|
|
16:45 | First time disclosure Discovery of the clinical candidate BI 1810631 (Zongertinib), a Selective HER2 Inhibitor for the Treatment of
HER2 Exon 20 Insertion Driven Tumors (OC10) |
Dr Birgit WILDING (BOEHRINGER INGELHEIM, Vienna, Austria) |
17:10 | Will Chemputers Dream of Electric Drugs (IL23) |
Prof. Leroy CRONIN (UNIVERSITY OF GLASGOW, Glasgow, United Kingdom) |
17:55 | Closing of the day
|
|
20:00 | Symposium Banquet sponsored by Selvita
|
|
Thursday September 7, 2023 |
08:30 | Session 7 |
|
| Session Chair |
Prof. Karl GADEMANN (UNIVERSITY OF ZÜRICH, Zürich, Switzerland) |
08:30 | Taking Molecular Glue Degraders to New Heights (IL24) |
Dr Etienne DONCKELE (MONTE ROSA THERAPEUTICS, Basel, Switzerland) |
09:15 | The beautiful simplicity of rearrangements – towards ideal reactions? (IL10) Chemistry Europe Speaker |
Prof. Nuno MAULIDE (UNIVERSITY OF VIENNA, Vienna, Austria) |
10:00 | RSC Medicinal Chemistry Lectureship Time to Shine for Constrained Peptides in Medicinal Chemistry (OC11) |
Prof. Christoph NITSCHE (AUSTRALIAN NATIONAL UNIVERSITY, Canberra, Australia) |
10:15 | Coffee-break and Exhibition
|
|
10:45 | Novel Modes of Enzyme Inhibition (IL26) |
Dr Anders JOHANSSON (ASTRAZENECA, Molndal, Sweden) |
11:30 | Natural Product Synthesis Through the Lens of Informatics (IL27) |
Prof. Ryan SHENVI (SCRIPPS RESEARCH, La Jolla, United States) |
12:15 | Closing Remarks & Prize Ceremony
|
Prof. Karl GADEMANN (UNIVERSITY OF ZÜRICH, Zürich, Switzerland) |
12:30 | End of the symposium
|
|